SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after reporting a strong Q4 earnings beat, achieving its first full year of GAAP profitability, and authorizing a $500 million stock buyback, fueling community debate between those anticipating a short squeeze and others concerned about modest growth guidance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as rising geopolitical tensions in the Middle East, impacting oil supply and prices, coupled with new trade probes, create market uncertainty. The community is debating if the current weakness signals a looming correction or if past resilience and "buy the dip" strategies will continue to defy negative macro headwinds.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic (LWLG) is buzzing following its development agreement with Tower Semiconductor, which investors view as a pivotal step towards integrating its high-performance electro-optic polymers into next-gen silicon photonics, with community speculation pointing to future collaborations with major AI chipmakers.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

IXHL is trending as it nears NASDAQ compliance and anticipation builds for End-of-Phase 2 results for its fast-tracked sleep apnea drug, IHL-42X. The community sees significant undervaluation and potential for a massive rally, tempered by ongoing discussions about the CEO's dilution history.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to its new collaboration with Novo Nordisk and the dismissal of their lawsuit, solidifying its position in the lucrative GLP-1 market. The community is actively discussing a short squeeze, fueled by high short interest and robust trading volume, as the stock demonstrates significant resilience even during broader market downturns.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending amid an imminent mainnet launch for its Goliath blockchain, which aims to establish real-world asset tokenization and global payment rails, coupled with recent international expansion efforts. Community sentiment is sharply divided, with strong bullish anticipation for this development countered by significant skepticism and warnings of potential 'sell the news' price action and historical market manipulation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is trending amid widespread investor frustration over its persistent stock decline and ongoing share dilution, which many attribute to perceived mismanagement and lack of communication from the CEO. While some in the community highlight the company's user growth and revenue as signs of undervaluation, the prevailing sentiment discusses significant losses and the stock's consistent failure to rebound, making it a popular short target.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

Anticipation is exceptionally high for New Era Energy's imminent announcement of a major hyperscaler tenant for its Texas Critical Data Centers, with recent land acquisitions further highlighting its strategic position in providing integrated power for the booming AI data center sector. While many investors remain bullish on the potential for a significant short squeeze, community discussions reflect a mix of confidence and growing frustration over the timing of the awaited tenant news.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency &lt;1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

HYPE is trending as the Hyperliquid platform showcases strong performance with high transaction volumes and new developments, like its predictions market, fueling community discussion around its growing utility in decentralized perpetual trading and deflationary tokenomics.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

RETIRE CRYPTO is trending with strong gains and active community-driven accumulation, as investors rally around its narrative of achieving financial freedom, viewing it as "The Last Play" to outperform major cryptocurrencies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Solid Biosciences Touts Encouraging Results For Duchenne Gene Therapy, FDA Talks Planned

Solid Biosciences stock fell 8% after new SGT-003 Duchenne trial data. Investors remain cautious despite promising results and FDA plans.read more...

Solid Biosciences (NASDAQ:SLDB) Shares Down 6.3% - Time to Sell?

Solid Biosciences (NASDAQ:SLDB) Stock Price Down 6.3% - What's Next...

Wedbush Reaffirms "Outperform" Rating for Solid Biosciences (NASDAQ:SLDB)

Wedbush reiterated an "outperform" rating and issued a $14.00 price target on shares of Solid Biosciences in a report on Wednesday...

Solid Biosciences (NASDAQ:SLDB) Reaches New 1-Year High - Should You Buy?

Solid Biosciences (NASDAQ:SLDB) Reaches New 52-Week High - Should You Buy...

Solid Biosciences (SLDB) Projected to Post Earnings on Thursday

Solid Biosciences (NASDAQ:SLDB) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Moderate Buy" by Brokerages

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the stock, Marketbeat.com...

Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells 16,644 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 16,644 shares of Solid Biosciences stock in a transaction that occurred on Wednesday, February 18th. The stock was sold...

Solid Biosciences (NASDAQ:SLDB) Insider Jessie Hanrahan Sells 4,134 Shares

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) insider Jessie Hanrahan sold 4,134 shares of Solid Biosciences stock in a transaction that occurred on Wednesday, February 18th. The stock was...

David Howton Sells 7,469 Shares of Solid Biosciences (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) COO David Howton sold 7,469 shares of Solid Biosciences stock in a transaction dated Wednesday, February 18th. The stock was sold at an average...

Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells $96,868.08 in Stock

Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 16,644 shares of the company's stock in a transaction on Wednesday, February 18th. The stock was sold at an average...

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

SLDB
Solid Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SLDB News

SLDBSolid Biosciences Inc